Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSPHENYTOIN Cause Hypoxic-ischaemic encephalopathy? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypoxic-ischaemic encephalopathy have been filed in association with FOSPHENYTOIN (CEREBYX). This represents 0.4% of all adverse event reports for FOSPHENYTOIN.

6
Reports of Hypoxic-ischaemic encephalopathy with FOSPHENYTOIN
0.4%
of all FOSPHENYTOIN reports
3
Deaths
2
Hospitalizations

How Dangerous Is Hypoxic-ischaemic encephalopathy From FOSPHENYTOIN?

Of the 6 reports, 3 (50.0%) resulted in death, 2 (33.3%) required hospitalization, and 4 (66.7%) were considered life-threatening.

Is Hypoxic-ischaemic encephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSPHENYTOIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does FOSPHENYTOIN Cause?

Drug ineffective (406) Off label use (164) Status epilepticus (82) Multiple-drug resistance (77) Cardiac arrest (72) Seizure (70) Drug ineffective for unapproved indication (63) Hypotension (56) Toxicity to various agents (53) Bradycardia (39)

What Other Drugs Cause Hypoxic-ischaemic encephalopathy?

MORPHINE (72) METHADONE (69) OXYCODONE (69) GABAPENTIN (65) FENTANYL (61) ACETAMINOPHEN (58) DIAZEPAM (55) ONDANSETRON (48) TRAMADOL (48) METFORMIN (45)

Which FOSPHENYTOIN Alternatives Have Lower Hypoxic-ischaemic encephalopathy Risk?

FOSPHENYTOIN vs FOSTAMATINIB FOSPHENYTOIN vs FOSTEMSAVIR TROMETHAMINE FOSPHENYTOIN vs FOTEMUSTINE FOSPHENYTOIN vs FRAMYCETIN FOSPHENYTOIN vs FREMANEZUMAB

Related Pages

FOSPHENYTOIN Full Profile All Hypoxic-ischaemic encephalopathy Reports All Drugs Causing Hypoxic-ischaemic encephalopathy FOSPHENYTOIN Demographics